Jennifer Doudna

The Innovative Genomics Institute, or IGI, and UC Berkeley have founded a lab to process diagnostic tests in response to the COVID-19, or the new coronavirus, pandemic.

For decades, women at UC Berkeley, acknowledged or unacknowledged, have pioneered their way through majors, studies and titles. Here are some of our favorite women throughout history who’ve fought against social norms to open doors for the rest of us at UC Berkeley.

UC Berkeley professor of molecular and cell biology and of chemistry Jennifer Doudna has been awarded the 2020 Wolf Prize in Medicine for her discovery of CRISPR-Cas9 gene-editing tool.

The United States Patent and Trademark Office issued the UC system's 20th CRISPR-Cas9 gene-editing technology patent with the arrival of the new year, according to a press release by Berkeley News.

The UC system was awarded a patent Tuesday, marking the university's 16th patent for the CRISPR-Cas9 patent portfolio — the highest number in the country.

The UC system and partners University of Vienna and Emmanuelle Charpentier were awarded a 12th patent for the CRISPR-Cas9 gene-editing technology. 

By the end of the summer, the UC system expects to receive five more patents, raising its portfolio to 15 total patents related to CRISPR technology.

British multinational corporation GlaxoSmithKline, or GSK, announced its partnership with UC Berkeley and UCSF on June 13 to build a state-of-the-art laboratory for CRISPR research, a revolutionary genetic modification technology.

On April 23, the U.S. Patent and Trademark Office issued UC Berkeley its fourth patent for CRISPR Cas-9, a revolutionary gene-editing technology.

After four years of litigation battles, the US Patent and Trademark Office, or USPTO, has finally approved a third CRISPR patent for the University of California.